TY  - GEN
AU  - Niederst,Matthew J
AU  - Sequist,Lecia V
AU  - Poirier,John T
AU  - Mermel,Craig H
AU  - Lockerman,Elizabeth L
AU  - Garcia,Angel R
AU  - Katayama,Ryohei
AU  - Costa,Carlotta
AU  - Ross,Kenneth N
AU  - Moran,Teresa
AU  - Howe,Emily
AU  - Fulton,Linnea E
AU  - Mulvey,Hillary E
AU  - Bernardo,Lindsay A
AU  - Mohamoud,Farhiya
AU  - Miyoshi,Norikatsu
AU  - VanderLaan,Paul A
AU  - Costa,Daniel B
AU  - Jänne,Pasi A
AU  - Borger,Darrell R
AU  - Ramaswamy,Sridhar
AU  - Shioda,Toshi
AU  - Iafrate,Anthony J
AU  - Getz,Gad
AU  - Rudin,Charles M
AU  - Mino-Kenudson,Mari
AU  - Engelman,Jeffrey A
TI  - RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
SN  - 2041-1723
PY  - 2016///0209
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adenocarcinoma of Lung
KW  - Afatinib
KW  - Aniline Compounds
KW  - pharmacology
KW  - Antineoplastic Agents
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Cell Line, Tumor
KW  - Disease Progression
KW  - Drug Resistance, Neoplasm
KW  - drug effects
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Erlotinib Hydrochloride
KW  - Gefitinib
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Lung
KW  - Lung Neoplasms
KW  - Mutation
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - genetics
KW  - Quinazolines
KW  - Recurrence
KW  - Retinoblastoma Protein
KW  - deficiency
KW  - Signal Transduction
KW  - Small Cell Lung Carcinoma
KW  - Sulfonamides
KW  - bcl-X Protein
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1038/ncomms7377
ER  -